ARCHIVES

Cytogen Corp.’s Imaging Agent ProstaScint Added to NCCN Prostate Cancer Guidelines.

This article is from The Cancer Letter archive.

Vol. 26 No. 13 | March 31, 2000

Download PDF Visit The Full Archive

Related Articles

Senate Committee Passes Bill To Speed FDA Approval Of Follow-On Biologics.

June 29, 2007

Antidepressant Provides Cool Choice For Hot Flashes

February 22, 2002

In Brief: LEO Sachs To Receive 1983 Bristol-Myers Award; 50 Percent Current Rate Achievable Now: Tylor

April 1, 1983

Abbott PCR Test For HCV Load Sensitive to Within 12 IU/mL

May 27, 2011

IOM Calls FDA Advisory System Sounds, Suggests Conflict Criteria Changes

March 5, 1993

NCI-Approved CTEP Trials For The Month of June

June 29, 2012